Audra Stinchcomb
Audra Stinchcomb
Professor, School of Pharmacy, University of Maryland, Baltimore
Verified email at
Cited by
Cited by
Challenges and opportunities in dermal/transdermal delivery
KS Paudel, M Milewski, CL Swadley, NK Brogden, P Ghosh, ...
Therapeutic delivery 1 (1), 109-131, 2010
Transdermal cannabidiol reduces inflammation and pain‐related behaviours in a rat model of arthritis
DC Hammell, LP Zhang, F Ma, SM Abshire, SL McIlwrath, AL Stinchcomb, ...
European journal of pain 20 (6), 936-948, 2016
Microneedles permit transdermal delivery of a skin-impermeant medication to humans
DP Wermeling, SL Banks, DA Hudson, HS Gill, J Gupta, MR Prausnitz, ...
Proceedings of the National Academy of Sciences 105 (6), 2058-2063, 2008
Characterization of the permeability barrier of human skin in vivo
F Pirot, YN Kalia, AL Stinchcomb, G Keating, A Bunge, RH Guy
Proceedings of the National Academy of Sciences 94 (4), 1562-1567, 1997
Human skin permeation of Δ8‐tetrahydrocannabinol, cannabidiol and cannabinol
AL Stinchcomb, S Valiveti, DC Hammell, DR Ramsey
Journal of pharmacy and pharmacology 56 (3), 291-297, 2004
Programmable transdermal drug delivery of nicotine using carbon nanotube membranes
J Wu, KS Paudel, C Strasinger, D Hammell, AL Stinchcomb, BJ Hinds
Proceedings of the National Academy of Sciences 107 (26), 11698-11702, 2010
Unique treatment potential of cannabidiol for the prevention of relapse to drug use: preclinical proof of principle
G Gonzalez-Cuevas, R Martin-Fardon, TM Kerr, DG Stouffer, LH Parsons, ...
Neuropsychopharmacology 43 (10), 2036-2045, 2018
Cannabidiol bioavailability after nasal and transdermal application: effect of permeation enhancers
KS Paudel, DC Hammell, RU Agu, S Valiveti, AL Stinchcomb
Drug development and industrial pharmacy 36 (9), 1088-1097, 2010
Formulations of cannabidiol and prodrugs of cannabidiol and methods of using the same
AL Stinchcomb, SL Banks
US Patent App. 12/769,519, 2010
Use of cannabidiol prodrugs in topical and transdermal administration with microneedles
AL Stinchcomb, SL Banks, MJ Golinski, JL Howard, DC Hammell
US Patent App. 12/873,248, 2011
In vitro experiment optimization for measuring tetrahydrocannabinol skin permeation
PVN Challapalli, AL Stinchcomb
International journal of pharmaceutics 241 (2), 329-339, 2002
Determining dermal absorption parameters in vivo from tape strip data
MB Reddy, AL Stinchcomb, RH Guy, AL Bunge
Pharmaceutical research 19, 292-298, 2002
Chemical uptake into human stratum corneum in vivo from volatile and non-volatile solvents
AL Stinchcomb, F Pirot, GD Touraille, AL Bunge, RH Guy
Pharmaceutical research 16, 1288-1293, 1999
Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same
AL Stinchcomb, MJ Golinski, DC Hammell, JL Howard, SL Banks
US Patent 8,293,786, 2012
Straight-chain naltrexone ester prodrugs: diffusion and concurrent esterase biotransformation in human skin
AL Stinchcomb, PW Swaan, O Ekabo, KK Harris, J Browe, DC Hammell, ...
Journal of pharmaceutical sciences 91 (12), 2571-2578, 2002
Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin
M Milewski, NK Brogden, AL Stinchcomb
Expert opinion on drug delivery 7 (5), 617-629, 2010
Transdermal delivery of naltrexone hydrochloride, naltrexol hydrochloride, and bis (hydroxy-methyl) propionyl-3-0 ester naltrexone using microneedles
A Stinchcomb, S Banks, R Pinninti
US Patent App. 11/812,249, 2008
Cannabinoid-Containing Compositions and Methods for Their Use
AL Stinchcomb, SL Banks
US Patent App. 13/318,208, 2012
Diclofenac delays micropore closure following microneedle treatment in human subjects
NK Brogden, M Milewski, P Ghosh, L Hardi, LJ Crofford, AL Stinchcomb
Journal of controlled release 163 (2), 220-229, 2012
Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs
SL Banks, RR Pinninti, HS Gill, KS Paudel, PA Crooks, NK Brogden, ...
Journal of pharmaceutical sciences 99 (7), 3072-3080, 2010
The system can't perform the operation now. Try again later.
Articles 1–20